Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models
- 26 November 2020
- book chapter
- Published by Springer Nature
- Vol. 2236, 19-28
Abstract
Myeloid-derived suppressor cells (MDSC) are immunosuppressive myeloid cells that accumulate in tumor sites and peripheral lymphoid organs such as the spleen. In murine cancer models, the spleen is a major reservoir for MDSC, representing an easily accessible tissue from which to isolate high numbers of these cell population for downstream applications. Here we describe an efficient method to phenotype as well as to isolate and assess the functionality of murine splenic MDSC.Keywords
This publication has 11 references indexed in Scilit:
- Fatty acid transport protein 2 reprograms neutrophils in cancerNature, 2019
- MDSC; the Most Important Cell You Have Never Heard OfTrends in Pharmacological Sciences, 2019
- Myeloid-derived suppressor cells coming of ageNature Immunology, 2018
- Myeloid-Derived Suppressor CellsCancer Immunology Research, 2017
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standardsNature Communications, 2016
- Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with IpilimumabClinical Cancer Research, 2016
- Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered ImmunityCancer Research, 2015
- History of myeloid-derived suppressor cellsNature Reviews Cancer, 2013
- Coordinated regulation of myeloid cells by tumoursNature Reviews Immunology, 2012
- The biology of myeloid‐derived suppressor cells: The blessing and the curse of morphological and functional heterogeneityEuropean Journal of Immunology, 2010